Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  pidilizumab
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
Lenalidomide and Pidilizumab in Treating Patients with Relapsed or Refractory Multiple Myeloma
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: OSU-13128, NCI-2014-00385, 2013C0180, NCT02077959
Monoclonal Antibody Therapy and Vaccine Therapy after Stem Cell Transplant in Treating Patients with Multiple Myeloma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 09-061, NCI-2010-01326, NCT01067287
Vaccine Therapy in Treating Patients with Acute Myeloid Leukemia in Complete Remission after Chemotherapy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 09-412, NCI-2010-01612, NCT01096602
Pidilizumab with or without Vaccine Therapy in Treating Patients with Stage IV Kidney Cancer
Status: Temporarily closed
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-178, NCI-2012-00259, NCT01441765
Efficacy and Safety Study of MDV9300 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Status: Not yet active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: MDV9300-01, NCI-2016-00175, NCT02653989
Pidilizumab in Treating Patients with Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NU 15H08, NCI-2015-01415, NCT02530125
Start Over